← Browse by Condition
Medical Condition
cystic fibrosis cf
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 3
ClinicalMetric tracks all active clinical trials for cystic fibrosis cf sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — cystic fibrosis cf Clinical Trials
How many clinical trials are currently recruiting for cystic fibrosis cf?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for cystic fibrosis cf, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cystic fibrosis cf?
cystic fibrosis cf research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cystic fibrosis cf clinical trial?
Eligibility criteria for cystic fibrosis cf trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06940531
Recruiting
Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis
Enrollment
300 pts
Location
United Kingdom
Sponsor
Alexander Horsley
NCT06998043 Phase 2
Recruiting
Study With Phage for CF Subjects With Pseudomonas Lung Infection
Enrollment
63 pts
Location
United States
Sponsor
BiomX Ltd
NCT06996951 Phase 3
Recruiting
Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy
Enrollment
64 pts
Location
United States
Sponsor
Indiana University
NCT07031323
Recruiting
OnTrackCF: Engagement, Feasibility, and Acceptability Study
Enrollment
60 pts
Location
United States
Sponsor
Boston Children's Hospital
NCT07436351
Recruiting
ACT With CF Self-Help Toolkit
Enrollment
60 pts
Location
United States
Sponsor
Thomas Jefferson University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology